Avenue Therapeutics Inc. (ATXI)
NASDAQ · Healthcare
Avenue Therapeutics Inc. Revenue 2024–2025
Avenue Therapeutics Inc. annual/quarterly revenue history and growth rate from 2024 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Avenue Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 0.
- Avenue Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 1.4 M.
- Avenue Therapeutics Inc. annual revenue for 2025 was 1.4 M.
- Avenue Therapeutics Inc. annual revenue for 2024 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Avenue Therapeutics Inc. Revenue — FAQ
Avenue Therapeutics Inc. (ATXI) revenue over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Avenue Therapeutics Inc.'s revenue?
Avenue Therapeutics Inc. (ATXI) reported revenue of $1M for fiscal 2025.
Where can I see ATXI's revenue history?
The chart and table above show Avenue Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.